반응식
[C:1]1([S:7]([C:10]2[C:18]3[C:13](=[CH:14][CH:15]=[C:16]([Cl:19])[CH:17]=3)[NH:12][C:11]=2[C:20](O)=[O:21])(=[O:9])=[O:8])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[CH3:23][N:24]1[CH:31]=[N:30][C:26]([CH2:27][CH2:28][NH2:29])=[CH:25]1>>[CH3:23][N:24]1[CH:25]=[C:26]([CH2:27][CH2:28][NH:29][C:20]([C:11]2[NH:12][C:13]3[C:18]([C:10]=2[S:7]([C:1]2[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=2)(=[O:8])=[O:9])=[CH:17][C:16]([Cl:19])=[CH:15][CH:14]=3)=[O:21])[N:30]=[CH:31]1참가 물질
3
실험 절차
Reaction of 3-phenylsulfonyl-5-chloroindole-2-carboxylic acid with 1-methylhistamine under the conditions of Example 37 provides the title compound.
출처 및 근거
- ORD 기록
- ord-f30d33a02a124acc91a98c094c48e24d
- 출처 데이터셋
- uspto-grants-1996_06
- 특허 번호
- US05527819
연결된 노트
불러오는 중…